UNC Health Care

Category: Treatment

UNC Chapel

January 5, 2017

Optogenetics Breakthrough: UNC scientists expand the use of light t...

The new research technique, developed by researchers at the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center, has the potential to illuminate the roles of previously inaccessible proteins important for health and disease.

Eye Health, Genetics, Research, Technology, Treatment

Read Article
Maki Tanioka

December 14, 2016

For invasive breast cancer, researchers identify biomarkers of trea...

UNC Lineberger researchers reported at the San Antonio Breast Cancer Symposium they have identified biomarkers they believe can be used as part of a larger model to predict how patients with HER2-positive operative breast cancer will respond to the targeted treatment trastuzumab, commercially known as Herceptin, and chemotherapy.

Breast Cancer, Research, Treatment

Read Article

December 14, 2016

Researchers developing model to predict if chemotherapy will work f...

In a study presented at the 2016 San Antonio Breast Cancer Symposium, UNC Lineberger researchers led by Katherine Hoadley, PhD, reported they developed a model that can predict which triple negative breast cancer patients will respond to chemotherapy.

Breast Cancer, Research, Treatment

Read Article

December 14, 2016

Brain metastasis persists despite improved targeted treatment for H...

At this year's San Antonio Breast Cancer Symposium, UNC Lineberger researchers and collaborators shared the outcomes of their investigation into the incidence of brain metastasis after a series of drugs were approved to treat HER2-positive metastatic breast cancer, starting with trastuzumab, also known as Herceptin, in the United States in 1998.

Breast Cancer, Neurology, Treatment

Read Article
John Buse

November 29, 2016

UNC clinical trials play crucial role in FDA approval for diabetes ...

Led by John Buse, MD, PhD, director of the UNC Diabetes Care Center, the clinical research of UNC doctors and the participation of thousands of patients culminates in a new, effective, and safe daily injectable drug to combat type-2 diabetes.

Diabetes, Research, Treatment

Read Article
Medical kit

November 21, 2016

HPDP receives $1.5 million to develop diabetes self-management educ...

Dr. Thomas Keyserling and Dr. Greg Randolph from the UNC School of Medicine are investigators in the project.

Diabetes, Education, Treatment

Read Article
Damaged chromosomes in Atr-mutant progenitors.

November 1, 2016

Could targeting a gene linked to microcephaly lead to a better brai...

UNC Lineberger researchers led by Dr. Timothy R. Gershon report preclinical findings showing promise for targeting a gene linked to microcephaly in infants as a treatment for medulloblastoma.

Brain Cancer, Genetics, Neurology, Treatment

Read Article
Louise Henderson

November 1, 2016

Study raises concerns about timely follow-up to positive mammogram ...

In the journal Cancer Epidemiology, Biomarkers & Prevention, researchers report that uninsured women under age 65 who received their mammogram at community screening clinics in North Carolina were less likely to get follow-up within a year of a positive mammogram, and had higher odds of missing a 60-day window for follow-up care.

Breast Cancer, Research, Social Justice, Treatment

Read Article
Nikolay Dokholyan

October 14, 2016

New ALS discovery: scientists reverse protein clumping involved in ...

By countering the tendency of the protein SOD1 to clump in motor neurons, researchers at the UNC School of Medicine find a way to protect neurons from toxic effects in lab experiments.

Genetics, Treatment

Read Article
Bryce Reeve

September 20, 2016

Racial gaps persist in how breast cancer survivors function, feel d...

A UNC Lineberger study published in the journal Breast Cancer Research and Treatment drew upon surveys that assessed health-related quality of life issues for women aged 20 to 74 years who lived in North Carolina and had breast cancer. The analysis was part of the third phase of the Carolina Breast Cancer Study.

Breast Cancer, Research, Treatment

Read Article
Harold Pillsbury

September 19, 2016

UNC hearing loss experts lead clinical trials of FDA-approved heari...

Ninety-seven percent of trial participants reported hearing improvements in the first year with the use of the SYNCHRONY EAS (Electric Acoustic Stimulation) Hearing Implant System. UNC implanted more patients than any other participating hearing center.

Hearing, Studies, Technology, Treatment

Read Article